Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F LANG

Showing results (621-630 of 1,072) with videos related to

Pageof 108
Sort By:
JIMD Reports|June 16, 2025
Placenta Pathologies in Two Patients With Glycogen Storage Disease Type Ia and PreeclampsiaV Laufs, A Hasenburg, M A Busch, et al.
Cell Death and Differentiation|April 14, 1999
Fas/CD95/Apo-I activates the acidic sphingomyelinase via caspasesB Brenner, K Ferlinz, H Grassmé, et al.
Fortschritte Der Medizin. Originalien|April 9, 2002
[Molecular biology of cystinuria]A Albers, C A Wagner, C Schmidt, et al.
The Journal of Biological Chemistry|December 20, 1996
Electrogenic properties and substrate specificity of the polyspecific rat cation transporter rOCT1A E Busch, S Quester, J C Ulzheimer, et al.
Nucleic Acids Research|February 21, 1998
The Organelle Genome Database Project (GOBASE)M Korab-Laskowska, P Rioux, N Brossard, et al.
Biochemical and Biophysical Research Communications|November 5, 1997
The CD40 ligand directly activates T-lymphocytes via tyrosine phosphorylation dependent PKC activationB Brenner, U Koppenhoefer, A Lepple-Wienhues, et al.
Onkologie|July 8, 2003
Second-line treatment of advanced gastric cancer with oxaliplatin plus raltitrexedK E Schmid, G V Kornek, B Schüll, et al.
Transplantation|October 27, 1994
Rat interleukin-2 immunoglobulin M fusion proteins are cytotoxic in vitro for cells expressing the IL-2 receptor and can abolish cell-mediated immunity in vivoW M Bogers, F Lang, K E Parker, et al.
Pharmeuropa Scientific Notes|March 12, 2009
Determination of the conversion factor for silymarin - a solution for the problems associated with new assay methods in the pharmacopoeiaF Gaedcke, M Hubbert, H Kurth, et al.
Molecular Cancer Therapeutics|March 16, 2005
Many human medulloblastoma tumors overexpress repressor element-1 silencing transcription (REST)/neuron-restrictive silencer factor, which can be functionally countered by REST-VP16Gregory N Fuller, Xiaohua Su, Roger E Price, et al.
Pageof 108

Showing results (621-630 of 1,072) with videos related to

Sort By:
Pageof 108
JIMD Reports|June 16, 2025
Placenta Pathologies in Two Patients With Glycogen Storage Disease Type Ia and PreeclampsiaV Laufs, A Hasenburg, M A Busch, et al.
Cell Death and Differentiation|April 14, 1999
Fas/CD95/Apo-I activates the acidic sphingomyelinase via caspasesB Brenner, K Ferlinz, H Grassmé, et al.
Fortschritte Der Medizin. Originalien|April 9, 2002
[Molecular biology of cystinuria]A Albers, C A Wagner, C Schmidt, et al.
The Journal of Biological Chemistry|December 20, 1996
Electrogenic properties and substrate specificity of the polyspecific rat cation transporter rOCT1A E Busch, S Quester, J C Ulzheimer, et al.
Nucleic Acids Research|February 21, 1998
The Organelle Genome Database Project (GOBASE)M Korab-Laskowska, P Rioux, N Brossard, et al.
Biochemical and Biophysical Research Communications|November 5, 1997
The CD40 ligand directly activates T-lymphocytes via tyrosine phosphorylation dependent PKC activationB Brenner, U Koppenhoefer, A Lepple-Wienhues, et al.
Onkologie|July 8, 2003
Second-line treatment of advanced gastric cancer with oxaliplatin plus raltitrexedK E Schmid, G V Kornek, B Schüll, et al.
Transplantation|October 27, 1994
Rat interleukin-2 immunoglobulin M fusion proteins are cytotoxic in vitro for cells expressing the IL-2 receptor and can abolish cell-mediated immunity in vivoW M Bogers, F Lang, K E Parker, et al.
Pharmeuropa Scientific Notes|March 12, 2009
Determination of the conversion factor for silymarin - a solution for the problems associated with new assay methods in the pharmacopoeiaF Gaedcke, M Hubbert, H Kurth, et al.
Molecular Cancer Therapeutics|March 16, 2005
Many human medulloblastoma tumors overexpress repressor element-1 silencing transcription (REST)/neuron-restrictive silencer factor, which can be functionally countered by REST-VP16Gregory N Fuller, Xiaohua Su, Roger E Price, et al.
Pageof 108